Adverse host factors exacerbate occult HIV-associated nephropathy

Am J Pathol. 2011 Oct;179(4):1681-92. doi: 10.1016/j.ajpath.2011.06.013. Epub 2011 Aug 24.

Abstract

In the present study, we hypothesized that HIV-1-induced occult HIV-associated nephropathy (HIVAN) would become apparent in the presence of adverse host factors. To test our hypothesis, Vpr mice (which display doxycycline-dependent Vpr expression in podocytes) with two, three, and four copies of the angiotensinogen (Agt) gene (Vpr-Agt-2, Vpr-Agt-3, and Vpr-Agt-4) were administered doxycycline for 3 weeks (to develop clinically occult HIVAN) followed by doxycycline-free water during the next 3 weeks. Subsequently, renal biomarkers were measured, and kidneys were harvested for renal histology. Vpr-Agt-2 developed neither proteinuria nor elevated blood pressure, and displayed minimal glomerular and tubular lesions only, without any microcyst formation. Vpr-Agt-3 showed mild glomerular and tubular lesions and microcyst formation, whereas Vpr-Agt-4 showed moderate proteinuria, hypertension, glomerular sclerosis, tubular dilation, microcysts, and expression of epithelial mesenchymal transition markers. Vpr-Agt-4 not only displayed enhanced renal tissue expression of Agt, renin, and angiotensin-converting enzyme, but also had higher renal tissue concentrations of angiotensin II. Moreover, renal cells in Vpr-Agt-4 showed enhanced expression of transforming growth factor-β, connective tissue growth factor, and vascular endothelial growth factor. These findings indicate that adverse host factors, such as the activation of the renin-angiotensin system, promote the progression of occult HIVAN to apparent HIVAN.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS-Associated Nephropathy / complications
  • AIDS-Associated Nephropathy / pathology*
  • AIDS-Associated Nephropathy / physiopathology
  • Angiotensin II / metabolism
  • Angiotensinogen / genetics
  • Angiotensinogen / metabolism
  • Animals
  • Biomarkers / metabolism
  • Blood Pressure / drug effects
  • Connective Tissue Growth Factor / metabolism
  • Doxycycline / pharmacology
  • Epithelial-Mesenchymal Transition / drug effects
  • Female
  • Gene Dosage / genetics
  • Genes, vpr
  • Host-Pathogen Interactions* / drug effects
  • Kidney / drug effects
  • Kidney / enzymology
  • Kidney / pathology
  • Male
  • Mice
  • Mice, Transgenic
  • Peptidyl-Dipeptidase A / metabolism
  • Phenotype
  • Proteinuria / complications
  • Proteinuria / pathology
  • Proteinuria / physiopathology
  • Renin / metabolism
  • Renin-Angiotensin System / drug effects
  • Transforming Growth Factor beta / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Biomarkers
  • CCN2 protein, mouse
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • Angiotensinogen
  • Angiotensin II
  • Connective Tissue Growth Factor
  • Peptidyl-Dipeptidase A
  • Renin
  • Doxycycline